Troponin T, a marker of cardiac myocyte injury measured in the blood with a new high sensitive assay, strongly predicts the clinical outcome of patients with stable and symptomatic chronic heart failure. We report here on new data obtained in a large international clinical trial.
|Number of pages||4|
|Journal||Recenti Progressi in Medicina|
|Publication status||Published - Oct 2008|
ASJC Scopus subject areas